SCYNEXIS
SCYX
#10667
Rank
C$33.96 M
Marketcap
C$3.41
Share price
-8.64%
Change (1 day)
310.48%
Change (1 year)

EPS for SCYNEXIS (SCYX)

EPS in 2026 (TTM): C-$7.18

According to SCYNEXIS's latest financial reports the company's current EPS (TTM) is C-$7.46. In 2025 the company made an earnings per share (EPS) of C-$1.95 an increase over its 2024 EPS that were of C-$5.05.

EPS history for SCYNEXIS from 2012 to 2026

Annual EPS

Year EPS Change
2026 (TTM)C-$7.18268.2%
2025C-$1.95-61.36%
2024C-$5.05-131.43%
2023C$16.06-195.24%
2022C-$16.8617.6%
2021C-$14.34-75.73%
2020C-$59.08-46.24%
2019C-$109.89242.14%
2018C-$32.12-70.21%
2017C-$107.83-40.51%
2016C-$181.24-41.04%
2015C-$307.43157.69%
2014C-$119.30-96.49%
2013C-$3,396307.85%
2012C-$832.63

EPS for similar companies or competitors

Company EPS EPS differencediff. Country
Galmed Pharmaceuticals
GLMD
C-$18.47 147.69%๐Ÿ‡ฎ๐Ÿ‡ฑ Israel
Catalyst Pharmaceuticals
CPRX
C$2.60-134.81%๐Ÿ‡บ๐Ÿ‡ธ USA
Catalent
CTLT
C-$9.08 21.73%๐Ÿ‡บ๐Ÿ‡ธ USA
KemPharm
KMPH
C-$1.42-80.96%๐Ÿ‡บ๐Ÿ‡ธ USA